PATH-study data available

The US National Institutes of Health (NIH) and the Food and Drug Administration (FDA) said yesterday that new data files from the Population Assessment of Tobacco and Health (PATH) Study had been released.
In a note issued through its Center for Tobacco Products, the FDA said the PATH Study was a household-based, nationally-representative, longitudinal cohort study of youth (12-17 years old) and adults in the US. The study was launched in 2011 to inform FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act.
The latest release includes:
* New Wave 3 Questionnaire Public-Use Files (PUF).
‘Data in the third wave were collected from October 2015 to October 2016,’ the FDA said. ‘Public-use questionnaire data files (PUFs) from the third wave of the PATH Study may be downloaded from the National Addiction & HIV Data Archive Program (NAHDAP) of the Inter-university Consortium for Political and Social Research (ICPSR).’
* Updates to Wave 1 Biomarker Restricted-Use Files (BRUF).
‘Data and documentation for five Wave 1 Biomarkers of Potential Harm assay panels were added to the PATH Study Biomarker Restricted-Use Files (BRUF),’ the note said. ‘Data in the first wave were collected from September 2013 to December 2014. The updated files were added to the existing biomarkers of tobacco exposure data in the BRUF, which include measurements of arsenic, creatinine, metals, polycyclic aromatic hydrocarbons, tobacco-specific nitrosamines, nicotine metabolites, and volatile organic compounds in urine and measurements of cotinine and hydroxycotinine in serum. Qualified researchers may apply for access to the PATH BRUF.’
The FDA said it encouraged researchers interested in the PATH Study to join the PATH Study Data User Forum. ‘The forum enables researchers using PATH Study data to submit and answer questions,’ it said. ‘Announcements, data releases and updates, new publications, upcoming events, and other information for PATH Study data users are also posted to the forum.’
There is more information here.